On this page
GFM1
G elongation factor mitochondrial 1
The GFM1 gene provides instructions for mitochondrial translation elongation factor G1, an enzyme essential for producing proteins within mitochondria, the cell's energy-generating organelles. GFM1 is vital for mitochondrial function, specifically in the process of translating genetic information from mitochondrial DNA into functional proteins.
GFM1 is located on the long (q) arm of chromosome 3, at band 3q25.32. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 3 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The GFM1 gene provides the blueprint for mitochondrial translation elongation factor G1, a protein vital for healthy mitochondrial function. Mitochondria are often referred to as the 'powerhouses' of the cell, generating the majority of the chemical energy required for cellular biochemical processes. The protein produced by the GFM1 gene is crucial for synthesising proteins from mitochondrial DNA (mtDNA), which are necessary for various metabolic pathways, including oxidative phosphorylation.
What the gene does
Mitochondrial translation elongation factor G1, encoded by the GFM1 gene, is an enzyme located inside mitochondria. Its primary role is to enable the synthesis of proteins from mitochondrial DNA, a process termed mitochondrial translation. While most proteins in the human body are encoded by nuclear DNA, a small yet essential group of proteins originate from mtDNA.
During protein synthesis, GFM1 orchestrates the movement of mitochondrial RNA (mtRNA) molecules along with ribosomes. Ribosomes are specialised complexes responsible for assembling amino acids into proteins. This coordinated action ensures the continuous and accurate formation of proteins until the synthesis is complete. These mtDNA-encoded proteins are fundamental for processes such as oxidative phosphorylation, which converts energy from food into a usable form for the cell. Impaired GFM1 function can therefore disrupt mitochondrial protein production and energy metabolism.
Video: Genetics 101
Chromosome location
The GFM1 gene is located on chromosome 3 at position 3q25.32. This specifies its exact physical address within the human genome.
Protein structure
The GFM1 protein consists of 751 amino acids and contains a critical functional region known as the tr-type G (Domain), found between amino acid positions 44 and 321. This domain is integral to its role as a mitochondrial translation elongation factor.
Key variants
Genetic changes within the GFM1 gene can affect its proper function, potentially leading to a range of health issues. These variations may include single nucleotide changes, insertions, or deletions that alter the protein's structure or how much of it is produced. Understanding these variants helps to clarify their potential clinical impact.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.114_115del | p.Val40fs | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
c.1424del | p.Arg475fs | Pathogenic/Likely pathogenic | ★★☆☆ | See cases |
c.1483G>T | p.Gly495Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
c.1525G>T | p.Glu509Ter | Pathogenic/Likely pathogenic | ★★☆☆ | GFM1-related disorder |
c.1632dup | p.Gly545fs | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
c.303dup | p.Ile102fs | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
c.725T>G | p.Leu242Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
c.787C>T | p.Gln263Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
c.928_929del | p.Leu310fs | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
c.974del | p.Asn325fs | Pathogenic/Likely pathogenic | ★★☆☆ | Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the GFM1 gene are associated with specific inherited conditions that impact mitochondrial function. One such condition is Combined oxidative phosphorylation deficiency 1, for which at least 18 different mutations in GFM1 have been identified. This severe disorder typically leads to neurological and liver dysfunction, and affected individuals generally do not survive beyond early childhood. The GFM1 gene is also associated with Leigh syndrome, another serious neurological disorder.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The GFM1 gene is included in several NHS Genomic Medicine Service national test panels, signifying its clinical importance within the UK healthcare system. It is categorised as 'green' on panels such as DDG2P, Foetal anomalies (R21), Inherited white matter disorders, Intellectual disability, Likely inborn error of metabolism (R98), Mitochondrial disorders, Possible mitochondrial disorder, nuclear genes (R63), Undiagnosed metabolic disorders, and White matter disorders and cerebral calcification - childhood onset. This classification indicates that variants in GFM1 are recognised as causing disease in these clinical contexts.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the GFM1 gene?
The GFM1 gene provides instructions for making mitochondrial translation elongation factor G1, an enzyme crucial for synthesising proteins from mitochondrial DNA. This process is vital for cellular energy production.
Where is the GFM1 gene located?
The GFM1 gene is located on chromosome 3 at position 3q25.32 within the human genome.
Why is the GFM1 gene important for mitochondria?
GFM1 is essential for mitochondria because its encoded protein helps translate mitochondrial DNA into functional proteins. These proteins are critical components of the machinery responsible for generating cellular energy.
References
- Ravn K, Schönewolf-Greulich B, Hansen RM. Neonatal mitochondrial hepatoencephalopathy caused by novel GFM1 mutations. Molecular genetics and metabolism reports. 2015. PMID: 26937387
- Balasubramaniam S, Choy YS, Talib A. Infantile Progressive Hepatoencephalomyopathy with Combined OXPHOS Deficiency due to Mutations in the Mitochondrial Translation Elongation Factor Gene GFM1. JIMD reports. 2012. PMID: 23430926
- Antonicka H, Sasarman F, Kennaway NG. The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Human molecular genetics. 2006. PMID: 16632485
- Coenen MJ, Antonicka H, Ugalde C. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. The New England journal of medicine. 2004. PMID: 15537906